1-ethyl-1,4-dihydro-5H-tetrazol-5-one, 95.0%, 100mg

(4-Hydroxy-3,5-dimethylphenyl)boronic acid, 95.0%, 1g

{[4-(1H-benzimidazol-2-yl)cyclohexyl]methyl}amine dihydrochloride, 95.0%, 1g

2-Phenylpyrimidine-5-carboxylic acid, 95.0%, 5g

2,5-Dichloro-4-iodopyridine, 95.0%, 5g

4-((3,4-DIMETHYLPHENYL)AMINO)-7-(PYRIDIN-4-YL)QUINOLINE-3-CARBOXAMIDE, 95%, 250mg

Matraz de fondo redondo con junta esmerilada estándar 50 ml NS 19/26

(S)-3-(4-benzylphenoxy)pyrrolidine hydrochloride, 98%, 500mg

(S)-(+)-2,2-Dimethyl-1,3-dioxolane-4-methanol>98.0%(GC)25g

[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 250mg

4-BROMO-1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-INDAZOLE, 95.0%, 500mg

(1-FLUOROCYCLOPROPYL)METHANOL, 95.0%, 250mg

Bolsa homogeneizadora, 400 ml, 180 mm, Altura, 300 mm, 500 Pieza(s)